Global Solid Tumors Drug Market Research Report 2021

July 2016 | 125 pages | ID: GE673264836EN
QYResearch

Abstracts

This report studies Solid Tumors Drug in Global market, especially in North America, Europe, China, Japan, India and Southeast Asia, focuses on top manufacturers in global market, with sales, price, revenue and market share for each manufacturer, covering

• F. Hoffmann-La Roche
• Novartis
• Celgene
• Johnson & Johnson
• Pfizer
• BMS
• Bayer
• AbbVie
• Boston Biomedical
• Eli Lilly
• GSK
• Merck
• Novartis
• Sanofi

Market Segment by Region, this report splits Global into several key Regions, with sales, revenue, market share and growth rate of Solid Tumors Drug in these regions, from 2011 to 2021 (forecast), like

• North America
• China
• Europe
• Japan
• India
• Southeast Asia

Split by product type, with sales, revenue, price, market share and growth rate of each type, can be divided into

• Type 1
• Type 2
• Type 3

Split by application, this report focuses on sales, market share and growth rate of Solid Tumors Drug in each application, can be divided into

• Application 1
• Application 2
• Application 3

Contents

Global Solid Tumors Drug Market Research Report 2021

1 SOLID TUMORS DRUG OVERVIEW

1.1 Product Overview and Scope of Solid Tumors Drug
1.2 Solid Tumors Drug Segment by Types
  1.2.1 Global Sales Market Share of Solid Tumors Drug by Type in 2015
  1.2.2 Type
  1.2.3 Type
  1.2.4 Type
1.3 Solid Tumors Drug Segment by Applications
  1.3.1 Application
  1.3.2 Application
  1.3.3 Application
1.4 Solid Tumors Drug Market by Regions
  1.4.1 North America Status and Prospect (2011-2021)
  1.4.2 China Status and Prospect (2011-2021)
  1.4.3 Europe Status and Prospect (2011-2021)
  1.4.4 Japan Status and Prospect (2011-2021)
  1.4.5 India Status and Prospect (2011-2021)
  1.4.6 Southeast Asia Status and Prospect (2011-2021)
1.5 Global Market Size (Value and Volume) of Solid Tumors Drug (2011-2021)
  1.5.1 Global Solid Tumors Drug Sales and Revenue (2011-2021)
  1.5.2 Global Solid Tumors Drug Sales and Growth Rate (2011-2021)
  1.5.3 Global Solid Tumors Drug Revenue and Growth Rate (2011-2021)

2 GLOBAL SOLID TUMORS DRUG MARKET COMPETITION BY MANUFACTURERS

2.1 Global Solid Tumors Drug Sales and Share by Manufacturers (2015 and 2016)
2.2 Global Solid Tumors Drug Revenue and Share by Manufacturers (2015 and 2016)
2.3 Manufacturers Solid Tumors Drug Manufacturing Base Distribution and Product Type
2.4 Competitive Situation and Trends
  2.4.1 Expansions
  2.4.2 New Product Launches
  2.4.3 Acquisitions
  2.4.4 Other Developments

3 GLOBAL SOLID TUMORS DRUG ANALYSIS BY REGION

3.1 Global Solid Tumors Drug Sales, Revenue and Market Share by Region (2011-2021)
  3.1.1 Global Solid Tumors Drug Sales Market Share by Region (2011-2021)
  3.1.2 Global Solid Tumors Drug Revenue Market Share by Region (2011-2021)
3.2 North America
  3.2.1 North America Solid Tumors Drug Sales, Revenue and Price (2011-2021)
  3.2.2 North America Solid Tumors Drug Sales, Revenue and Growth Rate (2011-2021)
3.3 Europe
  3.3.1 Europe Solid Tumors Drug Sales, Revenue and Price (2011-2021)
  3.3.2 Europe Solid Tumors Drug Sales, Revenue and Growth Rate (2011-2021)
3.4 China
  3.4.1 China Solid Tumors Drug Sales, Revenue and Price (2011-2021)
  3.4.2 China Solid Tumors Drug Sales, Revenue and Growth Rate (2011-2021)
3.5 Japan
  3.5.1 Japan Solid Tumors Drug Sales, Revenue and Price (2011-2021)
  3.5.2 Japan Solid Tumors Drug Sales, Revenue and Growth Rate (2011-2021)
3.6 India
  3.6.1 India Solid Tumors Drug Sales, Revenue and Price (2011-2021)
  3.6.2 India Solid Tumors Drug Sales, Revenue and Growth Rate (2011-2021)
3.7 Southeast Asia
  3.7.1 Southeast Asia Solid Tumors Drug Sales, Revenue and Price (2011-2021)
  3.7.2 Southeast Asia Solid Tumors Drug Sales, Revenue and Growth Rate (2011-2021)

4 GLOBAL SOLID TUMORS DRUG ANALYSIS BY TYPE

4.1 Global Solid Tumors Drug Sales, Revenue, Market Share and Growth Rate by Type (2011-2021)
  4.1.1 Global Solid Tumors Drug Sales and Market Share by Type (2011-2021)
  4.1.2 Global Solid Tumors Drug Revenue, Market Share and Growth Rate by Type (2011-2021)
4.2 Type 1 Sales, Revenue, Price and Growth (2011-2020)
4.3 Type 2 Sales, Revenue, Price and Growth (2011-2020)
4.4 Type 3 Sales, Revenue, Price and Growth (2011-2020)

5 GLOBAL SOLID TUMORS DRUG MARKET ANALYSIS BY APPLICATION

5.1 Global Solid Tumors Drug Sales and Market Share by Application (2011-2021)
5.2 Major Regions Solid Tumors Drug Sales by Application in 2015 and 2016
  5.2.1 North America Solid Tumors Drug Sales by Application
  5.2.2 Europe Solid Tumors Drug Sales by Application
  5.2.3 China Solid Tumors Drug Sales by Application
  5.2.4 Japan Solid Tumors Drug Sales by Application
  5.2.5 India Solid Tumors Drug Sales by Application
  5.2.6 Southeast Asia Solid Tumors Drug Sales by Application

6 GLOBAL SOLID TUMORS DRUG MANUFACTURERS ANALYSIS

6.1 F. Hoffmann-La Roche
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Solid Tumors Drug Product Overview
    6.1.2.1 Type
    6.1.2.2 Type
    6.1.2.3 Type
  6.1.3 Solid Tumors Drug Sales, Revenue, Price of F. Hoffmann-La Roche (2015 and 2016)
6.2 Novartis
  6.2.1 Company Basic Information, Manufacturing Base and Competitors
  6.2.2 Solid Tumors Drug Product Overview
    6.2.2.1 Type
    6.2.2.2 Type
    6.2.2.3 Type
  6.2.3 Solid Tumors Drug Sales, Revenue, Price of Novartis (2015 and 2016)
6.3 Celgene
  6.3.1 Company Basic Information, Manufacturing Base and Competitors
  6.3.2 Solid Tumors Drug Product Overview
    6.3.2.1 Type
    6.3.2.2 Type
    6.3.2.3 Type
  6.3.3 Solid Tumors Drug Sales, Revenue, Price of Celgene (2015 and 2016)
6.4 Johnson & Johnson
  6.4.1 Company Basic Information, Manufacturing Base and Competitors
  6.4.2 Solid Tumors Drug Product Overview
    6.4.2.1 Type
    6.4.2.2 Type
  6.4.3 Solid Tumors Drug Sales, Revenue, Price of Johnson & Johnson (2015 and 2016)
6.5 Pfizer
  6.5.1 Company Basic Information, Manufacturing Base and Competitors
  6.5.2 Solid Tumors Drug Product Overview
    6.5.2.1 Type
    6.5.2.2 Type
  6.5.3 Solid Tumors Drug Sales, Revenue, Price of Pfizer (2015 and 2016)
6.6 BMS
  6.6.1 Company Basic Information, Manufacturing Base and Competitors
  6.6.2 Solid Tumors Drug Product Overview
    6.6.2.1 Type
    6.6.2.2 Type
  6.6.3 Solid Tumors Drug Sales, Revenue, Price of BMS (2015 and 2016)
6.7 Bayer
  6.7.1 Company Basic Information, Manufacturing Base and Competitors
  6.7.2 Solid Tumors Drug Product Overview
    6.7.2.1 Type
    6.7.2.2 Type
  6.7.3 Solid Tumors Drug Sales, Revenue, Price of Bayer (2015 and 2016)
6.8 AbbVie
  6.8.1 Company Basic Information, Manufacturing Base and Competitors
  6.8.2 Solid Tumors Drug Product Overview
    6.8.2.1 Type
    6.8.2.2 Type
  6.8.3 Solid Tumors Drug Sales, Revenue, Price of AbbVie (2015 and 2016)
6.9 Boston Biomedical
  6.9.1 Company Basic Information, Manufacturing Base and Competitors
  6.9.2 Solid Tumors Drug Product Overview
    6.9.2.1 Type
    6.9.2.2 Type
  6.9.3 Solid Tumors Drug Sales, Revenue, Price of Boston Biomedical (2015 and 2016)
6.10 Eli Lilly
  6.10.1 Company Basic Information, Manufacturing Base and Competitors
  6.10.2 Solid Tumors Drug Product Overview
    6.10.2.1 Type
    6.10.2.2 Type
  6.10.3 Solid Tumors Drug Sales, Revenue, Price of Eli Lilly (2015 and 2016)
6.11 GSK
6.12 Merck
6.13 Novartis
6.14 Sanofi

7 INDUSTRY POLICY ANALYSIS

8 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Solid Tumors Drug
Figure Global Sales Market Share of Solid Tumors Drug by Type in 2015
Table Solid Tumors Drug Product Type of by Manufacturers
Table Solid Tumors Drug Sales Market Share by Application in 2015 and 2016
Figure North America Solid Tumors Drug Revenue and Growth Rate (2011-2021)
Figure China Solid Tumors Drug Revenue and Growth Rate (2011-2021)
Figure Europe Solid Tumors Drug Revenue and Growth Rate (2011-2021)
Figure Japan Solid Tumors Drug Revenue and Growth Rate (2011-2021)
Figure India Solid Tumors Drug Revenue and Growth Rate (2011-2021)
Figure Southeast Asia Solid Tumors Drug Revenue and Growth Rate (2011-2021)
Table Global Solid Tumors Drug Sales and Revenue (2011-2021)
Figure Global Solid Tumors Drug Sales and Growth Rate (2011-2021)
Figure Global Solid Tumors Drug Revenue and Growth Rate (2011-2021)
Table Global Solid Tumors Drug Sales of Key Manufacturers (2015 and 2016)
Table Global Solid Tumors Drug Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Solid Tumors Drug Sales Share by Manufacturers
Figure 2016 Solid Tumors Drug Sales Share by Manufacturers
Table Global Solid Tumors Drug Revenue by Manufacturers (2015 and 2016)
Table Global Solid Tumors Drug Revenue Share by Manufacturers (2015 and 2016)
Table 2015 Global Solid Tumors Drug Revenue Share by Manufacturers
Table 2016 Global Solid Tumors Drug Revenue Share by Manufacturers
Table Manufacturers Solid Tumors Drug Manufacturing Base Distribution and Product Type
Table Global Solid Tumors Drug Sales Market by Region (2011-2021)
Figure Global Solid Tumors Drug Sales Market by Region (2011-2021)
Figure Global Solid Tumors Drug Sales Market Share by Region (2011-2021)
Table Global Solid Tumors Drug Revenue Market by Region (2011-2021)
Table Global Solid Tumors Drug Revenue Market Share by Region (2011-2021)
Table North America Solid Tumors Drug Sales, Revenue and Price (2011-2021)
Figure North America Solid Tumors Drug Sales, Revenue and Growth Rate (2011-2021)
Table Europe Solid Tumors Drug Sales, Revenue and Price (2011-2021)
Figure Europe Solid Tumors Drug Sales, Revenue and Growth Rate (2011-2021)
Table China Solid Tumors Drug Sales, Revenue and Price (2011-2021)
Figure China Solid Tumors Drug Sales, Revenue and Growth Rate (2011-2021)
Table Japan Solid Tumors Drug Sales, Revenue and Price (2011-2021)
Figure Japan Solid Tumors Drug Sales, Revenue and Growth Rate (2011-2021)
Table India Solid Tumors Drug Sales, Revenue and Price (2011-2021)
Figure India Solid Tumors Drug Sales, Revenue and Growth Rate (2011-2021)
Table Southeast Asia Solid Tumors Drug Sales, Revenue and Price (2011-2021)
Figure Southeast Asia Solid Tumors Drug Sales, Revenue and Growth Rate (2011-2021)
Table Global Solid Tumors Drug Sales by Type (2011-2021)
Table Global Solid Tumors Drug Sales Share by Type (2011-2021)
Figure Sales Market Share of Solid Tumors Drug by Type (2011-2021)
Figure Global Solid Tumors Drug Sales Growth Rate by Type (2011-2021)
Table Global Solid Tumors Drug Revenue by Type (2011-2021)
Table Global Solid Tumors Drug Revenue Share by Type (2011-2021)
Figure Global Solid Tumors Drug Revenue Growth Rate by Type (2011-2021)
Figure Type 1 Sales, Revenue and Growth (2011-2021)
Figure Type 1 Price Trend (2011-2021)
Figure Type 2 Sales, Revenue and Growth (2011-2021)
Figure Type 2 Price Trend (2011-2021)
Figure Type 3 Sales, Revenue and Growth (2011-2021)
Figure Type 3 Price Trend (2011-2021)
Table Global Solid Tumors Drug Sales by Application (2011-2021)
Table Global Solid Tumors Drug Sales Market Share by Application (2011-2021)
Figure Global Solid Tumors Drug Sales Market Share by Application in 2015
Figure Global Solid Tumors Drug Sales Market Share by Application in 2021
Table North America Solid Tumors Drug Sales by Application (2015 and 2016)
Table Europe Solid Tumors Drug Sales by Application (2015 and 2016)
Table China Solid Tumors Drug Sales by Application (2015 and 2016)
Table Japan Solid Tumors Drug Sales by Application (2015 and 2016)
Table India Solid Tumors Drug Sales by Application (2015 and 2016)
Table Southeast Asia Solid Tumors Drug Sales by Application (2015 and 2016)
Table Global Solid Tumors Drug Sales Growth Rate by Application (2011-2021)
Figure Global Solid Tumors Drug Sales Growth Rate by Application (2011-2021)
Table F. Hoffmann-La Roche Basic Information List
Table Solid Tumors Drug Sales, Revenue, Price of F. Hoffmann-La Roche (2015 and 2016)
Table Novartis Basic Information List
Table Solid Tumors Drug Sales, Revenue, Price of Novartis (2015 and 2016)
Table Celgene Basic Information List
Table Solid Tumors Drug Sales, Revenue, Price of Celgene (2015 and 2016)
Table Johnson & Johnson Basic Information List
Table Solid Tumors Drug Sales, Revenue, Price of Johnson & Johnson (2015 and 2016)
Table Pfizer Basic Information List
Table Solid Tumors Drug Sales, Revenue, Price of Pfizer (2015 and 2016)
Table BMS Basic Information List
Table Solid Tumors Drug Sales, Revenue, Price of BMS (2015 and 2016)
Table Bayer Basic Information List
Table Solid Tumors Drug Sales, Revenue, Price of Bayer (2015 and 2016)
Table AbbVie Basic Information List
Table Solid Tumors Drug Sales, Revenue, Price of AbbVie (2015 and 2016)
Table Boston Biomedical Basic Information List
Table Solid Tumors Drug Sales, Revenue, Price of Boston Biomedical (2015 and 2016)
Table Eli Lilly Basic Information List
Table Solid Tumors Drug Sales, Revenue, Price of Eli Lilly (2015 and 2016)
Table GSK Basic Information List
Table Solid Tumors Drug Sales, Revenue, Price of GSK (2015 and 2016)
Table Merck Basic Information List
Table Solid Tumors Drug Sales, Revenue, Price of Merck (2015 and 2016)
Table Novartis Basic Information List
Table Solid Tumors Drug Sales, Revenue, Price of Novartis (2015 and 2016)
Table Sanofi Basic Information List
Table Solid Tumors Drug Sales, Revenue, Price of Sanofi (2015 and 2016)